RELATED CONTENT
November 2, 2012 — A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This noninvasive treatment technique may represent a potential new nonsurgical option for patients with the disease who have limited treatment options.
November 02, 2012 
July 20, 2012 — On July 6, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule that would revise several reimbursement payment policies and rates for services furnished under the Medicare Physician Fee Schedule (MPFS) as of January 1, 2013. The proposed changes reflect an overall 15 percent reduction in payment for radiation oncology services, equaling a $300 million loss for the provision of cancer care services, according to the American Society for Radiation Oncology (ASTRO).
July 20, 2012 July 6, 2012 — Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), meaning many more breast cancer patients could see their treatment times reduced by half, according to a study in the June issue of the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
July 06, 2012 
November 2, 2009 — Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented Nov. 2, at the American Society for Radiation Oncology’s (ASTRO) 51st Annual Meeting in Chicago.
November 02, 2009 November 2, 2009 — High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, Nov.
November 02, 2009 November 2, 2009 — Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session Nov.
November 02, 2009 April 6, 2009 - The American Society for Radiation Oncology (ASTRO) has recently updated its patient brochure “Plain Talk for Radiation Therapy Patients: Stereotactic Radiation” to include information about stereotactic radiation.
April 06, 2009 April 2, 2009 - In female cancer patients of reproductive age, radiation treatment directly to the ovaries should be avoided because there is a direct relationship between certain types of radiation therapy and fertility problems, according to a review in the April 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation
April 01, 2009 March 17, 2009 - The American Society for Radiation Oncology (ASTRO) said that Calypso Medical, Standard Imaging and Varian Medical Systems have been elected to serve three-year terms on ASTRO's Corporate Advisory Council.
March 16, 2009 March 16, 2009 - According to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics (the official journal of ASTRO), preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments.
March 16, 2009